| Patent application number | Description | Published |
|---|
| 20110044882 | METHOD OF MAKING HIGH PURITY LITHIUM HYDROXIDE AND HYDROCHLORIC ACID - The present invention relates to a process for producing high purity lithium hydroxide monohydrate, comprising following steps: concentrating a lithium containing brine; purifying the brine to remove or to reduce the concentrations of ions other than lithium; adjusting the pH of the brine to about 10.5 to 11 to further remove cations other than lithium, if necessary; neutralizing the brine with acid; purifying the brine to reduce the total concentration of calcium and magnesium to less than 150 ppb via ion exchange; electrolyzing the brine to generate a lithium hydroxide solution containing less than 150 ppb total calcium and magnesium, with chlorine and hydrogen gas as byproducts; producing hydrochloric acid via combustion of the chlorine gas with excess hydrogen and subsequent scrubbing of the resultant gas stream with purified water, if elected to do so; and concentrating and crystallizing the lithium hydroxide solution to produce lithium hydroxide monohydrate crystals. | 02-24-2011 |
| 20110180418 | METHODS FOR THE ELECTROLYTIC PRODUCTION OF XYLO-PENT-1,5-DIOSE - Method and electrochemical cells for producing xylo-pent-1,5-diose are provided. The xylo-pent-1,5-diose may be formed in a solution initially comprising D-glucuronic acid or D-glucuronic acid glycoside. The xylo-pent-1,5-diose may be formed by electrochemical oxidative decarboxylation of the D-glucuronic acid or D-glucuronic acid glycoside in the solution in the presence of a graphite foil electrode with improved current efficiency and/or current density. | 07-28-2011 |
| 20110203929 | RECOVERY OF LITHIUM FROM AQUEOUS SOLUTIONS - A method for recovering lithium as lithium hydroxide by feeding an aqueous stream containing lithium ions to a bipolar electrodialysis cell, wherein the cell forms a lithium hydroxide solution. An apparatus or system for practicing the method is also provided. | 08-25-2011 |
| Patent application number | Description | Published |
|---|
| 20080305167 | TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS - Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is substantially not released when the dosage form is administered intact, such that the ratio of the amount of antagonist released from said dosage form after tampering to the amount of said antagonist released from said intact dosage form is about 4:1 or greater, based on the in-vitro dissolution at 1 hour of said dosage form in 900 ml of Simulated Gastric Fluid using a USP Type II (paddle) apparatus at 75 rpm at 37 degrees C. wherein said agonist and antagonist are interdispersed and are not isolated from each other in two distinct layers. | 12-11-2008 |
| 20080306104 | TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS - Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is substantially not released when the dosage form is administered intact, such that the ratio of the amount of antagonist released from said dosage form after tampering to the amount of said antagonist released from said intact dosage form is about 4:1 or greater, based on the in-vitro dissolution at 1 hour of said dosage form in 900 ml of Simulated Gastric Fluid using a USP Type II (paddle) apparatus at 75 rpm at 37 degrees C. wherein said agonist and antagonist are interdispersed and are not isolated from each other in two distinct layers. | 12-11-2008 |
| 20080311198 | TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS - Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is substantially not released when the dosage form is administered intact, such that the ratio of the amount of antagonist released from said dosage form after tampering to the amount of said antagonist released from said intact dosage form is about 4:1 or greater, based on the in-vitro dissolution at 1 hour of said dosage form in 900 ml of Simulated Gastric Fluid using a USP Type II (paddle) apparatus at 75 rpm at 37 degrees C. wherein said agonist and antagonist are interdispersed and are not isolated from each other in two distinct layers. | 12-18-2008 |
| 20080311199 | TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS - Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is substantially not released when the dosage form is administered intact, such that the ratio of the amount of antagonist released from said dosage form after tampering to the amount of said antagonist released from said intact dosage form is about 4:1 or greater, based on the in-vitro dissolution at 1 hour of said dosage form in 900 ml of Simulated Gastric Fluid using a USP Type II (paddle) apparatus at 75 rpm at 37 degrees C. wherein said agonist and antagonist are interdispersed and are not isolated from each other in two distinct layers. | 12-18-2008 |
| 20110097404 | TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS - Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is not released when the dosage form is administered orally intact. | 04-28-2011 |
| Patent application number | Description | Published |
|---|
| 20090192389 | INNOVATIVE COMPONENTS FOR AN ULTRASONIC ARC SCANNING APPARATUS - Embodiments of the present invention are directed to various aspects of imaging systems, including permeable and impermeable barriers separating liquid compartments, one of which contains the object to be imaged and the other an ultrasonic transducer, a fluidic bearing between a transducer carriage and guide supporting the carriage, a linear motor for the carriage, and a location sensing device for the carriage. | 07-30-2009 |
| 20100004537 | PROCEDURES FOR AN ULTRASONIC ARC SCANNING APPARATUS - Embodiments of the present invention are directed to methods of rapidly obtaining ultrasonic images of the eye using a set of procedural options that can be automated by a positioning mechanism that can be controlled by software. | 01-07-2010 |
| 20110099718 | METHOD OF POSITIONING A PATIENT FOR MEDICAL PROCEDURES - A method and apparatus are disclosed for a method for securing a patient for a medical procedure and specifically for an innovative headrest system for securing a patient for an ocular imaging procedure. The approach avoids the need for linkages and sliding rods and such. Instead, it relies on three independently movable face rests (two for the forehead or temples and one for the chin) each with a deformable cushion that is urged into conformity with the patient's head and chin during an adjustment phase of operation. Once a comfortable position and suitable conforming shape is achieved, the positions of the face rests are rigidly fixed and the shape of the cushions are rendered rigid and non-deformable, by application of a light vacuum, for the procedural or imaging phase of operation. | 05-05-2011 |
